GVHD Alliance to Honor Steven Pavletic With the Inaugural Lukas D. Wartman GVHD Achievement Award

In recognition of the first-ever GVHD (graft-versus-host disease) Day, the American Society for Transplantation and Cellular Therapy (ASTCT), a member of the GVHD Alliance, is proud to announce Steven Pavletic, MD, MS, as the inaugural recipient of the Lukas D. Wartman GVHD Achievement Award.  The GVHD Achievement Award is named in honor of Lukas Wartman, … Read more

ASTCT to Present Distinguished Honors at the 2023 Tandem Meetings

American Society for Transplantation and Cellular Therapy (ASTCT) will present top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® on Saturday, Feb. 18 in Orlando, Florida.  Fred Appelbaum, MD will receive the 2023 ASTCT Lifetime Achievement Award. Dr. … Read more

Massive Bio Supports Cancer Associations

Massive Bio, which matches cancer patients to clinical trials of innovative new therapies, has launched “Donation for Life,” a new awareness campaign to support cancer associations and foundations in the United States and Europe. During the campaign, Massive Bio will select different organizations that support cancer patients to be recipients of donations. The campaign will … Read more

UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022

Over 129 community oncology healthcare professionals, including 81 prescribers, representing 35 community oncology practices across the nation, registered to join Cornerstone Specialty Network, LLC for its second annual European Society for Medical Oncology (ESMO) 2022 Data Review Symposium on Oct. 27, 2022. The program was chaired by Edith A. Perez, MD (Mayo Clinic, Jacksonville, FL), Sujith … Read more

illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer

illumiSonics Inc., a medical tissue imaging company, announced today the appointment of Jochen Schweizer as COO.  The company is further strengthening the executive team as they commercialize their Cancer detection and diagnostics products using the proprietary PARS imaging platform technology. Mr. Schweizer previously held executive positions at Danaher/Leica, responsible for the Microsurgery Portfolio in the business … Read more

illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer

illumiSonics Inc., a medical tissue imaging company, announced today the appointment of Jochen Schweizer as COO. The company is further strengthening the executive team as they commercialize their cancer detection and diagnostics products using the proprietary PARS imaging platform technology. Mr. Schweizer previously held executive positions at Danaher/Leica, responsible for the Microsurgery Portfolio in the business … Read more

illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer

illumiSonics Inc., a medical tissue imaging company, announced today the appointment of Jochen Schweizer as COO. The company is further strengthening the executive team as they commercialize their cancer detection and diagnostics products using the proprietary PARS imaging platform technology. Mr. Schweizer previously held executive positions at Danaher/Leica, responsible for the Microsurgery Portfolio in the business … Read more

Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform

Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and timely predicts a patient’s response to cancer treatment. The company has raised an additional USD 8 million from leading investors to facilitate scaling of clinical studies and expansion of commercial international … Read more

CytoImmune Therapeutics Appoints Renowned Oncologist and Immunologist as New Chief Executive Officer

CytoImmune Therapeutics, a privately-held cell therapy company focused on developing natural killer (NK) immune cells to fight cancer, announces the appointment of Christina Coughlin M.D., Ph.D., as their Chief Executive Officer. Dr. Coughlin will provide strategic leadership for the recently launched biotech and its clinical-stage pipeline of engineered NK cell therapies designed to improve outcomes … Read more

3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation

In real-world usage and in clinical trials, interferon (IFN) in a variety of forms has shown high rates of hematologic and molecular responses in many patients with rare blood cancers known as myeloproliferative neoplasms (MPNs). Other patients have no significant response, and some develop drug resistance to recombinant interferon over time. A report summarizing a three-year … Read more